Unveiling the Surface and the Ultrastructure of Palladized Fungal Biotemplates.

In this paper, two biosystems based on filamentous fungi and Pd nanoparticles (NPs) were synthesized and structurally characterized. In the first case, results concerning the integration and distribution of Pd-NPs on Phialomyces macrosporus revealed that nanoparticles are accumulated on the cell wall, keeping the cytoplasm isolated from abiotic particles. However, the Penicillium sp. species showed an unexpected internalization of Pd-NPs in the fungal cytosol, becoming a promising biosystem to further studies of in vivo catalytic reactions. Next, we report a new solution-based strategy to prepare palladized biohybrids through sequential reduction of Pd2+ ions over previously harvested fungus/Au-NP composites. The chemical composition and the morphology of the biohybrid surface were characterized using a combination of scanning electron microscopy, transmission electron microscopy, and photoelectron spectroscopy. The deposition of Pd0 over the fungal surface produced biohybrids with a combination of Au and Pd in the NPs. Interestingly, other chemical species such as Au+ and Pd2+ are also observed on the outermost wall of microorganisms. Finally, the application of A. niger/AuPd-NP biohybrids in the 3-methyl-2-buten-1-ol hydrogenation reaction is presented for the first time. Biohybrids with a high fraction of Pd0 are active for this catalytic reaction.

Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation.

BACKGROUND: Acute hepatitis E virus (HEV) infection in solid organ transplant recipients is rare, but can cause severe hepatic and extrahepatic complications. We sought to identify the pretransplant prevalence of HEV infection in heart and kidney candidates and any associated risk factors for infection. MATERIAL AND METHODS: Stored frozen serum from patients undergoing evaluation for transplant was tested for HEV immunoglobulin G (IgG) antibodies and HEV RNA. All patients were seen at Mayo Clinic Hospital, Phoenix, Arizona, with 333 patients evaluated for heart (n = 132) or kidney (n = 201) transplant. HEV IgG antibodies (anti-HEV IgG) were measured by enzyme-linked immunosorbent assay, and HEV RNA by a noncommercial nucleic acid amplification assay. RESULTS: The prevalence of anti-HEV IgG was 11.4% (15/132) for heart transplant candidates and 8.5% (17/201) for kidney transplant candidates, with an overall seroprevalence of 9.6% (32/333). None of the patients tested positive for HEV RNA in the serum. On multivariable analysis, age older than 60 years was associated with HEV infection (adjusted odds ratio, 3.34; 95% CI, 1.54-7.24; P = 0.002). CONCLUSIONS: We conclude that there was no evidence of acute HEV infection in this pretransplant population and that older age seems to be associated with positive anti-HEV IgG.

ACTN3 and ACE genotypes in elite Jamaican and US sprinters.

UNLABELLED: The angiotensin-converting enzyme (ACE) and the alpha-actinin-3 (ACTN3) genes are two of the most studied "performance genes" and both have been associated with sprint/power phenotypes and elite performance. PURPOSE: To investigate the association between the ACE and the ACTN3 genotypes and sprint athlete status in elite Jamaican and US African American sprinters. METHODS: The ACTN3 R577X and the ACE I/D and A22982G (rs4363) genotype distributions of elite Jamaican (J-A; N = 116) and US sprinters (US-A; N = 114) were compared with controls from the Jamaican (J-C; N = 311) and US African American (US-C; N = 191) populations. Frequency differences between groups were assessed by exact test. RESULTS: For ACTN3, the XX genotype was found to be at very low frequency in both athlete and control cohorts (J-C = 2%, J-A = 3%, US-C = 4%, US-A = 2%). Athletes did not differ from controls in ACTN3 genotype distribution (J, P = 0.87; US, P = 0.58). Similarly, neither US nor Jamaican athletes differed from controls in genotype at ACE I/D (J, P = 0.44; US, P = 0.37). Jamaican athletes did not differ from controls for A22982G genotype (P = 0.28), although US sprinters did (P = 0.029), displaying an excess of heterozygotes relative to controls but no excess of GG homozygotes (US-C = 22%, US-A = 18%). CONCLUSIONS: Given that ACTN3 XX genotype is negatively associated with elite sprint athlete status, the underlying low frequency in these populations eliminates the possibility of replicating this association in Jamaican and US African American sprinters. The finding of no excess in ACE DD or GG genotypes in elite sprint athletes relative to controls suggests that ACE genotype is not a determinant of elite sprint athlete status.